CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 47 enrolled
Drug / intervention
transcutaneous electrical nerve stimulation (TENS):Enraf Nonius® S82 modeldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05362383
NCT05362383N/ACompleted

Use of Transcutaneous Electrical Nerve Stimulation (TENS) for the Recovery of Oral Function After Orthognathic Surgery

Universidad Complutense de Madrid·interventional·Posted May 5, 2022·Updated May 11, 2022

In Brief

A clinical study evaluating transcutaneous electrical nerve stimulation (TENS):Enraf Nonius® S82 model for Orthognathic Surgery and 2 related conditions. Completed, enrolled 47 participants across 1 site.

Detailed Summary

Oral functions of patients are markedly diminished immediately after orthognathic surgery, and novel approaches are needed to accelerate their recovery. The aim of this study is to examine the usefulness of weekly applications of transcutaneous electrical nerve stimulation (TENS) for this purpose, based on evidence of its effectiveness in other types of patients with muscle alterations. The main objective is to determine whether weekly TENS applications can increase the bite force and jaw opening in patients undergoing orthognathic surgery and decrease their pain and inflammation

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 5, 2022
Enrollment StartFeb 1, 2013
Primary CompletionMay 18, 2018
Study CompletionJan 15, 2020
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 4.2 years ago

Interventions

transcutaneous electrical nerve stimulation (TENS):Enraf Nonius® S82 modeldevice

Will be used TENS device with a maximum frequency of 120 Hz and an intensity range of 0 to 99.5 milliampere. TENS electrodes (diameter 35-52 mm) will be placed bilaterally on mandibular elevator muscles, on the superficial masseter muscle above the gonial angle, and bilaterally on the anterior temporal muscle. The device will be applied in an identical manner to all patients in both groups and kept in position for the same time period (30 min) and for the control group the the device will be not switched on